Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach ; volume:15 ; number:1 ; day:15 ; month:1 ; year:2020 ; pages:1-6 ; date:12.2020
Addiction science & clinical practice ; 15, Heft 1 (15.1.2020), 1-6, 12.2020
- Urheber
-
Rozylo, Jennifer
Mitchell, Keren
Nikoo, Mohammadali
Durante, S. Elise
Barbic, Skye P.
Lin, Daniel
Mathias, Steve
Azar, Pouya
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-020-0177-x
- URN
-
urn:nbn:de:101:1-2020042003194403547873
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rozylo, Jennifer
- Mitchell, Keren
- Nikoo, Mohammadali
- Durante, S. Elise
- Barbic, Skye P.
- Lin, Daniel
- Mathias, Steve
- Azar, Pouya
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation